Multisystem Inflammatory Syndrome in Adults clinical trials at University of California Health
3 in progress, 1 open to eligible people
Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
open to eligible people ages 0-20
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The…
at UCLA
MIS-C Comparative Effectiveness Study
Sorry, in progress, not accepting new patients
In March 2020, children exposed to the virus that causes the COVID-19 illness, SARS-CoV-2, presented with fever and significant inflammation about a month after exposure to the virus. Some children were sick enough to require care in the intensive…
at UCSD
Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children
Sorry, in progress, not accepting new patients
Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory…
at UCSD
Our lead scientists for Multisystem Inflammatory Syndrome in Adults research studies include Jaime Deville Adriana Tremoulet, MD, MAS.
Last updated: